A potential harmful effect of dexamethasone in non-severe COVID-19: results from the COPPER-pilot study
Janwillem Kocks, Marjan Kerkhof, Jan Scherpenisse, Aimée van de Maat, Iris van Geer-Postmus, Thomas le Rütte, Jan G. Schaart, Reinold O.B. Gans, Huib A.M. Kerstjens
Abstract
<b>This study suggests caution when prescribing systemic corticosteroids to patients with #COVID19 who show mild-to-moderate pulmonary symptoms because a harmful effect cannot be excluded</b>https://bit.ly/3P4nOjQ
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)DexamethasoneSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakBit (key)Intensive care medicineInternal medicineVirologyDiseaseOutbreakComputer scienceInfectious disease (medical specialty)Computer securityCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research